標題: Titlebook: Use Case Driven Object Modeling with UMLTheory and Practice; Theory and Practice Doug Rosenberg,Matt Stephens Book 2007Latest edition Don R [打印本頁] 作者: 縮寫 時間: 2025-3-21 18:35
書目名稱Use Case Driven Object Modeling with UMLTheory and Practice影響因子(影響力)
書目名稱Use Case Driven Object Modeling with UMLTheory and Practice影響因子(影響力)學科排名
書目名稱Use Case Driven Object Modeling with UMLTheory and Practice網(wǎng)絡公開度
書目名稱Use Case Driven Object Modeling with UMLTheory and Practice網(wǎng)絡公開度學科排名
書目名稱Use Case Driven Object Modeling with UMLTheory and Practice被引頻次
書目名稱Use Case Driven Object Modeling with UMLTheory and Practice被引頻次學科排名
書目名稱Use Case Driven Object Modeling with UMLTheory and Practice年度引用
書目名稱Use Case Driven Object Modeling with UMLTheory and Practice年度引用學科排名
書目名稱Use Case Driven Object Modeling with UMLTheory and Practice讀者反饋
書目名稱Use Case Driven Object Modeling with UMLTheory and Practice讀者反饋學科排名
作者: 性冷淡 時間: 2025-3-22 00:02
r insight into the data generating mechanism by explaining the variability in the data. The choice of residual variance model should be based on the data and theoretical considerations of the data and what is known about the data generating mechanism. In addition to the constant variance assumption 作者: 脖子 時間: 2025-3-22 00:41 作者: Mucosa 時間: 2025-3-22 05:59
mans. This process is often the rate-limiting step in the elimination of a compound from the body and/or in the formation of active (reactive) metabolites. Large differences have been shown to occur between different species, and among different individuals within one species, in their capacity to o作者: 死貓他燒焦 時間: 2025-3-22 10:21
agents. The modern form of a drug delivery system should minimize side effects and reduce both dosage and dosage frequency. Nanoparticle drug delivery focuses on maximizing drug efficacy and minimizing cytotoxicity. Fine-tuning nanoparticle properties for effective drug delivery involves addressing 作者: Exuberance 時間: 2025-3-22 13:57
is time has been spent following and, hopefully in some instances, contributing to advancement of the discipline of pharmacokinetics. During the last 40 years, pharmacokinetics has grown from a fledgling in the 1950s to an adult in the 1990s. The late development of the discipline of pharmacokinetic作者: 訓誡 時間: 2025-3-22 18:15
at has reached to provide drug concentration in the blood on and above the minimum effective concentration (MEC) upon its administration. The bioavailability is once again classified as absolute bioavailability and relative bioavailability. The ratio of the bioavailability of a drug administered by 作者: Anonymous 時間: 2025-3-23 00:31
ical angiogenesis while minimizing damage to the neurosensory retina. This is perhaps best exemplified by the development of therapies targeting the potent angiogenic growth factor and vascular permeability mediator, vascular endothelial growth factor (VEGF). Anti-VEGF therapies, initially introduce作者: 東西 時間: 2025-3-23 03:57 作者: 運動吧 時間: 2025-3-23 07:35
ipheral nervous system of mammals regenerate spontaneously after injury..The relationships between neurons and nonneuronal cells are vital for the neuro’s maintenance and function. Trauma alters these relationships, causing nonneuronal cell proliferation, and in adult mammalian CNS creates an enviro作者: 愛好 時間: 2025-3-23 13:10 作者: fodlder 時間: 2025-3-23 17:10 作者: 懶鬼才會衰弱 時間: 2025-3-23 18:54 作者: 進步 時間: 2025-3-24 01:58 作者: 存心 時間: 2025-3-24 03:42 作者: Ingrained 時間: 2025-3-24 10:29 作者: 江湖郎中 時間: 2025-3-24 11:27
Domain Modelinge is speaking Swahili. Every time someone speaks, people glean whatever slivers of meaning they can, and then nod as if they’ve understood perfectly. They then walk away with a completely wrong interpretation of what the speaker was really trying to say.作者: SLING 時間: 2025-3-24 17:39
Use Case Modelingnts of a system, so that you can reasonably create a design from them. They help you to answer some fundamental questions: . A surprising amount of what your software does is dictated by the way in which users must interact with it.作者: 種子 時間: 2025-3-24 19:16 作者: Interferons 時間: 2025-3-25 02:42
Robustness Analysisbustness analysis, helps you to bridge the gap from analysis to design by doing exactly that. In a nutshell, it’s a way of analyzing your use case text and identifying a first-guess set of objects for each use case. These are classified into boundary objects, entity objects, and controllers (which are often more like functions than objects).作者: magnate 時間: 2025-3-25 05:22
Critical Design Reviewiguate the use case text and discover any missing domain classes, you’ve held a Preliminary Design Review (PDR) to make sure the use cases match up with what the customer really wants, and you’ve carefully crafted a detailed design for the use cases you’re implementing in this release.作者: bronchiole 時間: 2025-3-25 09:56 作者: follicular-unit 時間: 2025-3-25 11:40
Addressing Requirements differences between requirements, use cases, and behavior (operations). Since we talked about use cases in Chapter 3, allocating behavior in Chapter 8, and a whole series of techniques driven by use cases and operations in the subsequent chapters, it’s easier to talk about requirements in terms of how they contrast with those items.作者: Default 時間: 2025-3-25 19:51
Preliminary Design ReviewThe Preliminary Design Review (PDR) session helps you to make sure that the robustness diagrams, the domain model, and the use case text all match each other. This review is the “gateway” between the preliminary design and detailed design stages, for each package of use cases.作者: 愛社交 時間: 2025-3-25 22:09
Technical ArchitectureThe purpose of technical architecture (TA) is to get an overall feel for the system that you’re going to be developing. Will it be a web-based system? Or a rich-client system in VB .NET or Java Swing? Does it need to use a specific application framework (e.g., a company-standard framework)?作者: 駁船 時間: 2025-3-26 02:45
Sequence DiagramsOnce you’ve finished robustness analysis, and you’ve held a preliminary design review, it’s time to begin the detailed design effort. By this time, your use case text should be complete, correct, detailed, and explicit. In short, your use cases should be in a state where you can create a detailed design from them.作者: calumniate 時間: 2025-3-26 07:15
Code Review and Model UpdateDuring coding, it’s likely that you’ll have made a few changes to the design, so the code will now be slightly out of sync with the design diagrams. A depressingly common reaction at this stage is to deem the design documentation obsolete, throw it away, and continue all subsequent development work without doing any more design work.作者: 小卷發(fā) 時間: 2025-3-26 08:50
Design-Driven TestingIt’s easy to look at a program module and say, “There, that’s finished,” but this sense of completion can be deceptive. How do you know for sure that the code completes all the use case scenarios—not just the basic courses, but the alternate courses, too?作者: 屈尊 時間: 2025-3-26 16:23 作者: 有節(jié)制 時間: 2025-3-26 18:07
http://image.papertrans.cn/u/image/944422.jpg作者: Ophthalmoscope 時間: 2025-3-27 00:25 作者: 表主動 時間: 2025-3-27 04:00 作者: encomiast 時間: 2025-3-27 07:31
Introduction to ICONIX Processsign. There’s always pressure from management to jump to code, to start coding prematurely because progress on software projects tends to get measured by how much code exists. ICONIX Process, as shown in the chapter’s opening figure, is a minimalist, streamlined approach that focuses on that area th作者: Organization 時間: 2025-3-27 11:31
Domain Modelinge is speaking Swahili. Every time someone speaks, people glean whatever slivers of meaning they can, and then nod as if they’ve understood perfectly. They then walk away with a completely wrong interpretation of what the speaker was really trying to say.作者: 討人喜歡 時間: 2025-3-27 13:35 作者: LITHE 時間: 2025-3-27 18:21 作者: 充氣女 時間: 2025-3-28 00:09 作者: Hyperplasia 時間: 2025-3-28 03:34
Critical Design Reviewiguate the use case text and discover any missing domain classes, you’ve held a Preliminary Design Review (PDR) to make sure the use cases match up with what the customer really wants, and you’ve carefully crafted a detailed design for the use cases you’re implementing in this release.作者: guardianship 時間: 2025-3-28 08:45 作者: 巫婆 時間: 2025-3-28 12:01 作者: Alienated 時間: 2025-3-28 16:22 作者: 殺菌劑 時間: 2025-3-28 20:34 作者: 牛馬之尿 時間: 2025-3-29 02:33
Book 2007Latest editionlysis and design errors, shows how to detect and fix them, and suggests how to avoid making the same errors in the future. The book also encourages you to examine its UML examples and to search for specific errors. You‘ll get clues, then later receive the answers during review sessions toward the end of the book..作者: maladorit 時間: 2025-3-29 06:32
(and using!) ICONIX.Authors’ previous book on use case drive.Use Case Driven Object Modeling with UML: Theory and Practice. shows how to drive an object-oriented software design from use case all the way through coding and testing, based on the minimalist, UML-based ICONIX process. In addition to a 作者: agnostic 時間: 2025-3-29 07:36 作者: hematuria 時間: 2025-3-29 11:59
tes other than that route. When plasma or whole blood or urinary excretion data of a drug upon its administration by any routes other than the intravenous route are compared to those upon the drug administration by any routes other than the same route or the intravenous route, the ratio of the bioavailability of the drug is called ..作者: 溫和女人 時間: 2025-3-29 17:03 作者: Benign 時間: 2025-3-29 22:52
blood flow to the myocardium. Most drugs administered to improve the function of the cardiovascular system have multiple mechanisms of action and may have more than one effect on the cardiovascular system, so they must be administered with caution and titrated to effect, and their effects monitored closely.作者: 背帶 時間: 2025-3-30 00:39
d molecular mechanisms leading to the pathology of Alzheimer’s disease and on the multiple, possible, therapeutic opportunities ahead of us. The field of research is enormous and therefore therapeutic targets that have been selected for this volume seem the most hopeful and for which there is a soli作者: 夸張 時間: 2025-3-30 05:22 作者: Tempor 時間: 2025-3-30 08:28
nd to vary several-fold (5). It has been suggested that individuality in the metabolism of environmental carcinogens which require metabolic activation may help to explain individual differences in the sensitivity of people to the carcinogenic action of such chemicals (6).作者: 蚊帳 時間: 2025-3-30 13:28 作者: 滑動 時間: 2025-3-30 18:34
his presentation will be to focus on the pharmacokinetic principles that must be considered in the design, analysis, and interpretation of studies of the effect of age on the disposition and pharmacologic activity of drugs.作者: Nebulizer 時間: 2025-3-30 22:34
commencement of these therapies. This chapter will provide an overview of the current understanding of MRONJ in relation to incidence, pathophysiology, risk factors and clinical presentation. In addition, it will provide a brief overview of approaches to prevention and management of this condition.
